8-KLeadership Changes

Elevance Health, Inc. 8-K Report, Executive Changes (Feb 22, 2023)

Filed February 22, 2023For Securities:ELV

Summary

Elevance Health, Inc. (ELV) announced a key executive leadership transition in its 8-K filing dated February 22, 2023. Gloria M. McCarthy will be stepping down from her role as Executive Vice President and Chief Administrative Officer, effective April 1, 2023. She will transition to a new position as Special Advisor to the Chief Executive Officer. This change in the Chief Administrative Officer role is the primary focus of this filing. Investors should monitor how this transition impacts operational oversight and administrative functions within the company. While McCarthy's move to a special advisor role suggests a continued, albeit different, involvement, the specific responsibilities and impact on strategic execution will be of interest going forward.

Key Highlights

  • 1Gloria M. McCarthy is transitioning from EVP and Chief Administrative Officer to Special Advisor to the CEO, effective April 1, 2023.
  • 2The filing specifically addresses changes in certain officers as per Item 5.02.
  • 3The new role for Ms. McCarthy as Special Advisor indicates continued engagement with senior leadership.
  • 4No other significant financial or operational changes were detailed in this specific 8-K filing.
  • 5This is primarily an announcement of an executive role change, not a financial results update.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce a change in Elevance Health's executive leadership. Specifically, it details Gloria M. McCarthy's transition from her role as Executive Vice President and Chief Administrative Officer to a new position as Special Advisor to the Chief Executive Officer.

The change in roles for Gloria M. McCarthy will be effective April 1, 2023.

No, Gloria M. McCarthy will not be leaving Elevance Health. She is transitioning to a new role as Special Advisor to the Chief Executive Officer.

No, this specific 8-K filing does not provide any updates on Elevance Health's financial performance or results. It solely focuses on an executive leadership transition.